AN2 Therapeutics

ANTXNASDAQ
$2.15
-0.08-3.59%
At Close: -
$2.16
0.010.47%
After Hours: 9:29 AM EDT
15 minutes delayed
AN2 Therapeutics (ANTX) ForecastNewsEarningsGuidanceDividendsAnalyst Ratings

Insider Trades

Short Interest

AN2 Therapeutics (NASDAQ:ANTX) Stock, Insider Trading Activity

AN2 Therapeutics: Insider buying and selling updated today.

Insider Shares Owned
396.798K
Insider Percentage Owned
1.33%
Institutional Shares Held
1.327M
Institutional Percentage Held
4.45%
Jan 19, 2024Joseph Zakrzewski—-100K$19.11-$1.91MSELL-16.55%504.079KJan 18View
Jan 18, 2024Kabeer Aziz—-100K$19.65-$1.97MSELL-20.94%377.542KJan 16View
Jan 18, 2024Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC—-100K$19.65-$1.97MSELL-20.94%377.542KJan 16View
Jan 17, 2024Robin Shane ReadnourDIRECTOR-1.425K$21.91-$31.23KSELL-0.29%485.073KJan 12View
Jan 12, 2024Robin Shane ReadnourDIRECTOR-3.669K$21.93-$80.44KSELL-0.75%485.792KJan 10View
Jan 11, 2024Kevin Michael KrauseCHIEF STRATEGY OFFICER0$12.36-$115.35KSELL-OPTIONS0.00%1.914KJan 09View
Jan 04, 2024Kevin Michael KrauseCHIEF STRATEGY OFFICER0$10.27-$50.88KSELL-OPTIONS0.00%1.914KJan 02View
Jan 04, 2024Eric EasomCHIEF EXECUTIVE OFFICER-2.777K$20.09-$55.80KSELL-2.72%99.188KJan 02View
Nov 16, 2023Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC—-1.81K$16.15-$29.22KSELL-0.46%393.449KNov 14View
Nov 16, 2023Kabeer Aziz—-1.81K$16.15-$29.22KSELL-0.46%393.449KNov 14View
Oct 03, 2023Kabeer Aziz—-104.773K$16.27-$1.70MSELL-21.02%393.737KSep 29 - Oct 02View
Oct 03, 2023Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC—-104.773K$16.27-$1.70MSELL-21.02%393.737KSep 29 - Oct 02View
Sep 29, 2023Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC—-9.357K$16.11-$150.71KSELL-2.23%410.403KSep 27 - Sep 28View
Sep 29, 2023Kabeer Aziz—-9.357K$16.11-$150.71KSELL-2.23%410.403KSep 27 - Sep 28View
Sep 15, 2023Kabeer Aziz—-400$16.00-$6.40KSELL-0.10%411.893KSep 13View
Sep 15, 2023Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC—-400$16.00-$6.40KSELL-0.10%411.893KSep 13View
Sep 08, 2023Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC—-7.14K$16.03-$114.48KSELL-1.70%411.957KSep 06 - Sep 07View
Sep 08, 2023Kabeer Aziz—-7.14K$16.03-$114.48KSELL-1.70%411.957KSep 06 - Sep 07View
Aug 25, 2023Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LPAdjuvant Capital GP LPAdjuvant Capital Management LLC—-400$16.00-$6.40KSELL-0.10%413.092KAug 23View
Aug 25, 2023Kabeer Aziz—-400$16.00-$6.40KSELL-0.10%413.092KAug 23View
Aug 22, 2023RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah10% OWNER1.777778M$9.00$16.00MBUY47.11%5.551295MAug 18View
May 15, 2023Eric EasomCHIEF EXECUTIVE OFFICER10K$5.38$53.77KBUY0.91%1.112824MMay 15View
Nov 14, 2022Eric EasomCHIEF EXECUTIVE OFFICER-4.436K$15.32-$67.97KSELL-47.48%4.907KNov 10 - Nov 14View
Nov 09, 2022Eric EasomCHIEF EXECUTIVE OFFICER-17.166K$15.60-$267.79KSELL-77.77%4.907KNov 08 - Nov 09View
Nov 07, 2022Eric EasomCHIEF EXECUTIVE OFFICER-35.196K$15.86-$558.27KSELL-87.76%4.907KNov 03 - Nov 07View
Nov 02, 2022Eric EasomCHIEF EXECUTIVE OFFICER-4.232K$15.27-$64.63KSELL-46.31%4.907KOct 31 - Nov 02View
Oct 28, 2022Eric EasomCHIEF EXECUTIVE OFFICER-2.607K$15.18-$39.58KSELL-34.70%4.907KOct 27 - Oct 28View
Oct 26, 2022Eric EasomCHIEF EXECUTIVE OFFICER-9.35K$15.76-$147.36KSELL-65.58%4.907KOct 24 - Oct 26View
Oct 24, 2022Eric EasomCHIEF EXECUTIVE OFFICER-21.244K$16.47-$349.91KSELL-81.24%4.907KOct 20 - Oct 21View
Aug 05, 2022RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah10% OWNER1.909K$7.51$14.33KBUY0.05%3.773517MAug 03 - Aug 04View
Jul 28, 2022RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah10% OWNER23.219K$7.78$180.67KBUY0.62%3.771608MJul 26 - Jul 27View
Jun 23, 2022RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah10% OWNER302$7.99$2.41KBUY0.01%3.748389MJun 21View
Jun 15, 2022RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah10% OWNER81.424K$7.95$647.40KBUY2.22%3.748087MJun 13 - Jun 14View
Mar 31, 2022Robin Shane ReadnourDIRECTOR904.955K$15.00$2.30MBUY∞487.592KMar 29View
Mar 31, 2022Adjuvant Global Health Technology Fund LPAdjuvant Global Health Technology Fund DE LP10% OWNER2.59738M$15.00$2.50MBUY∞2.210735MMar 29View
Mar 31, 2022Kabeer AzizDIRECTOR2.59738M$15.00$2.50MBUY∞2.210735MMar 29View
Mar 31, 2022RA CAPITAL MANAGEMENT LPRA Capital Healthcare Fund LPRA Capital Nexus Fund II LPPeter KolchinskyRajeev Shah10% OWNER3.666663M$15.00$25.00MBUY∞415.612KMar 29View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.

People Also Watch